Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DGT01I
|
|||
| Drug Name |
MYK-224
|
|||
| Indication | Obstructive hypertrophic cardiomyopathy [ICD-11: BC43.12; ICD-10: I42.1] | Phase 2 | [1] | |
| Company |
Bristol-Myers Squibb
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT05556343) A Phase 2a, Open-label, Pilot Study to Evaluate Efficacy, Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of MYK-224 in Participants With Symptomatic Hypertrophic Cardiomyopathy and Left Ventricular Outflow Tract Obstruction (MERCUTIO). U.S.National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.